493 related articles for article (PubMed ID: 10092062)
1. Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren's syndrome.
Nakamura H; Kawakami A; Tominaga M; Migita K; Kawabe Y; Nakamura T; Eguchi K
Lab Invest; 1999 Mar; 79(3):261-9. PubMed ID: 10092062
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome.
Kobayashi M; Kawano S; Hatachi S; Kurimoto C; Okazaki T; Iwai Y; Honjo T; Tanaka Y; Minato N; Komori T; Maeda S; Kumagai S
J Rheumatol; 2005 Nov; 32(11):2156-63. PubMed ID: 16265694
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of apoptosis and bcl-2 in Sjögren's syndrome.
Manganelli P; Quaini F; Andreoli AM; Lagrasta C; Pilato FP; Zuccarelli A; Monteverdi R; D'Aversa C; Olivetti G
J Rheumatol; 1997 Aug; 24(8):1552-7. PubMed ID: 9263150
[TBL] [Abstract][Full Text] [Related]
4. Novel role of CD40 in Fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren's syndrome.
Ping L; Ogawa N; Sugai S
Arthritis Rheum; 2005 Feb; 52(2):573-81. PubMed ID: 15692983
[TBL] [Abstract][Full Text] [Related]
5. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
[TBL] [Abstract][Full Text] [Related]
6. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
7. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
[TBL] [Abstract][Full Text] [Related]
8. Lymphoproliferative disorders in Sjögren's syndrome.
Masaki Y; Sugai S
Autoimmun Rev; 2004 Mar; 3(3):175-82. PubMed ID: 15110228
[TBL] [Abstract][Full Text] [Related]
9. c-myc mRNA expression in minor salivary glands of patients with Sjögren's syndrome.
Skopouli FN; Kousvelari EE; Mertz P; Jaffe ES; Fox PC; Moutsopoulos HM
J Rheumatol; 1992 May; 19(5):693-9. PubMed ID: 1613697
[TBL] [Abstract][Full Text] [Related]
10. Elevated proapoptotic Bax and caspase 3 activation in the NOD.scid model of Sjögren's syndrome.
Masago R; Aiba-Masago S; Talal N; Zuluaga FJ; Al-Hashimi I; Moody M; Lau CA; Peck AB; Brayer J; Humphreys-Beher MG; Dang H
Arthritis Rheum; 2001 Mar; 44(3):693-702. PubMed ID: 11263785
[TBL] [Abstract][Full Text] [Related]
11. G-protein signaling abnormalities mediated by CD95 in salivary epithelial cells.
Liu XB; Masago R; Kong L; Zhang BX; Masago S; Vela-Roch N; Katz MS; Yeh CK; Zhang GH; Talal N; Dang H
Cell Death Differ; 2000 Nov; 7(11):1119-26. PubMed ID: 11139286
[TBL] [Abstract][Full Text] [Related]
12. CD40, CD154, Bax and Bcl-2 expression in Sjögren's syndrome salivary glands: a putative anti-apoptotic role during its effector phases.
Ohlsson M; Szodoray P; Loro LL; Johannessen AC; Jonsson R
Scand J Immunol; 2002 Dec; 56(6):561-71. PubMed ID: 12472667
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of human T lymphotropic virus type I-infected T cells in the salivary glands of patients with human T lymphotropic virus type I-associated Sjögren's syndrome.
Ohyama Y; Nakamura S; Hara H; Shinohara M; Sasaki M; Ikebe-Hiroki A; Mouri T; Tsunawaki S; Abe K; Shirasuna K; Nomoto K
Arthritis Rheum; 1998 Nov; 41(11):1972-8. PubMed ID: 9811052
[TBL] [Abstract][Full Text] [Related]
14. TCR in Fas-sensitive T cells from labial salivary glands of patients with Sjögren's syndrome.
Sumida T; Matsumoto I; Murata H; Namekawa T; Matsumura R; Tomioka H; Iwamoto I; Saito Y; Mizushima Y; Hasunuma T; Maeda T; Nishioka K
J Immunol; 1997 Jan; 158(2):1020-5. PubMed ID: 8993025
[TBL] [Abstract][Full Text] [Related]
15. [Sjögren's syndrome as a lymphoaggressive disorder; bcl-2 expression in lymphocytes infiltrated in salivary glands].
Takeshita S; Sugai S
Nihon Rinsho; 1995 Oct; 53(10):2440-5. PubMed ID: 8531352
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry of the B-cell component in lower lip salivary glands of Sjögren's syndrome and healthy subjects.
Larsson A; Bredberg A; Henriksson G; Manthorpe R; Sallmyr A
Scand J Immunol; 2005 Jan; 61(1):98-107. PubMed ID: 15644129
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.
Daridon C; Devauchelle V; Hutin P; Le Berre R; Martins-Carvalho C; Bendaoud B; Dueymes M; Saraux A; Youinou P; Pers JO
Arthritis Rheum; 2007 Apr; 56(4):1134-44. PubMed ID: 17393395
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor in salivary glands from patients with Sjögren's syndrome: functional analysis by human salivary gland cell line.
Kawakami A; Nakashima K; Tamai M; Nakamura H; Iwanaga N; Fujikawa K; Aramaki T; Arima K; Iwamoto N; Ichinose K; Kamachi M; Ida H; Origuchi T; Eguchi K
J Rheumatol; 2007 May; 34(5):1019-26. PubMed ID: 17407216
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis.
Zhang X; Li L; Choe J; Krajewski S; Reed JC; Thompson C; Choi YS
Cell Immunol; 1996 Oct; 173(1):149-54. PubMed ID: 8871610
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelium and lymphocyte adhesion molecules in minor salivary glands of patients with Sjogren's syndrome.
Aziz KE; McCluskey PJ; Montanaro A; Wakefield D
J Clin Lab Immunol; 1992 Jan; 37(1):39-49. PubMed ID: 1339235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
